Menu
Back to Blog
treatments 13 min read

How Often Can You Get Gel Injections? Frequency and Retreatment Guide

How often can you get gel injections in your knee? Learn retreatment schedules by brand, Medicare's 6-month rule, long-term safety data, and when to consider switching treatments.

By Joint Pain Authority Team

How Often Can You Get Gel Injections? Frequency and Retreatment Guide

Key Takeaways

  • Standard retreatment interval is every 6 months — this is the minimum required by Medicare and most insurers
  • There is no lifetime limit on how many gel injection courses you can receive
  • Repeat injections maintain or improve effectiveness — studies show cumulative benefit through the 4th course and beyond
  • Long-term safety data spanning 10+ years shows no cumulative harm from repeated treatments
  • Brand choice affects your schedule — single-injection options mean fewer office visits per course
  • Switching brands is allowed if your current one stops working well

Quick Answer: The Standard Retreatment Schedule

If your first gel injection worked well, the next one follows a predictable timeline. Most patients repeat treatment every 6 to 12 months, depending on how long their relief lasts.

Typical Retreatment Timeline
Your ResponseRetreat EveryNotes
Excellent9–12 monthsWait until symptoms return
Average6–9 monthsMost common pattern
Shorter relief6 monthsTreat as soon as insurance allows
Preventive approachEvery 6 monthsScheduled before symptoms return

The 6-month minimum is not a safety restriction. It reflects insurance reimbursement policies and the typical duration of relief. From a medical standpoint, hyaluronic acid is naturally broken down by your body, so there is no pharmacological reason to wait longer.

For a deeper look at whether repeat treatments are safe and effective, see our full guide on repeating gel injections.


Medicare Retreatment Rules: The 6-Month Minimum

Medicare Part B covers repeat gel injections under Local Coverage Determinations (LCDs) that apply across all regions. The rules are straightforward but require careful documentation.

Medicare Coverage Requirements for Repeat Courses
6-month minimum between treatment courses per joint
Documented benefit from the previous course (VAS or WOMAC scores)
Confirmed OA diagnosis with radiographic evidence
Failed conservative therapy (exercise, PT, medications still inadequate)
No lifetime cap — coverage continues as long as treatment remains medically necessary

How the 6-Month Clock Works

The 6-month interval starts from the last injection of your previous course, not the first. If you finished a 3-injection Euflexxa series on January 15, the earliest your next course can begin is July 15.

Documentation Your Doctor Should Keep

Medicare LCD Article A56157 requires your medical chart to show:

  • Pain score improvement (VAS or WOMAC) compared to pre-treatment baseline
  • Continued functional limitations that justify treatment
  • Evidence that other treatments were tried or are not tolerable
  • Clinical evaluation within the preceding 6 months

Tip: Track your own pain levels weekly on a 0–10 scale. Bring these notes to your appointments. This personal record supports your doctor’s documentation and strengthens your case for continued coverage.

For the full breakdown of Medicare Part B coverage for gel injections, including costs and copay estimates, see our dedicated insurance guide.


Brand-by-Brand Retreatment Schedule

All 8 FDA-approved HA brands follow the same 6-month retreatment interval, but they differ in how many injections make up each course. This affects your time commitment and copay structure.

BrandInjections per CourseScheduleSourceRetreatment Interval
Synvisc-One1Single visitAvian6 months minimum
Durolane1Single visitNon-avian6 months minimum
Gel-One1Single visitAvian6 months minimum
Monovisc1Single visitNon-avian6 months minimum
Euflexxa3Weekly x 3 weeksNon-avian6 months minimum
Orthovisc3–4Weekly x 3–4 weeksNon-avian6 months minimum
Supartz FX3–5Weekly x 3–5 weeksAvian6 months minimum
Hyalgan5Weekly x 5 weeksAvian6 months minimum

What This Means for Annual Treatment Burden

If you repeat every 6 months:

  • Single-injection brands (Synvisc-One, Durolane, Gel-One, Monovisc): 2 office visits per year
  • 3-injection brands (Euflexxa, Orthovisc): 6–8 office visits per year
  • 5-injection brands (Hyalgan, Supartz FX): 10 office visits per year

For patients who value convenience or have mobility challenges, single-injection options can significantly reduce the treatment burden. Our HA brands comparison guide covers the full differences between formulations, and our single-injection vs. series comparison examines which approach may work best for you.


Do Repeat Injections Work as Well?

This is the question patients ask most: will each injection keep working, or do they lose effectiveness over time? The research is encouraging.

Clinical Evidence on Repeat Efficacy

What the Studies Show

Cumulative benefit through 4+ courses: A longitudinal study following patients through multiple treatment cycles found VAS pain scores improved by 66% after the fourth course (from 5.0 to 1.7 on a 10-point scale), with improvements maintained across all WOMAC domains — pain, stiffness, and physical function.

25-month sustained improvement: Patients receiving repeat injections every 6 months for over 2 years showed pain that continued to decrease at each follow-up, ultimately reaching a 55% reduction from baseline.

No tolerance or resistance: Unlike some medications, there is no evidence that your body develops resistance to hyaluronic acid. Each course works through the same mechanical lubrication process.

The Role of Disease Progression

While the injections themselves maintain effectiveness, your underlying arthritis does not stand still. Over years of treatment, some patients notice:

  • Relief duration gradually shortening (from 9 months down to 6 months, for example)
  • Peak improvement being slightly less dramatic
  • More advanced disease responding less completely

This is not the injection failing — it is the condition progressing. Even with this gradual change, many patients successfully use gel injections for 5 to 10 years or longer as part of a comprehensive management plan.


Long-Term Safety of Repeated Gel Injections

Safety Data at a Glance
10-year study: No cumulative adverse effects in patients receiving injections every 6 months for a full decade
30-month Hyalgan study: 25 total injections (5 courses) showed consistent safety across all cycles
No cartilage damage: Unlike cortisone, HA injections show no harmful effects on joint tissue
No systemic toxicity: Hyaluronic acid is naturally metabolized and cleared through lymphatic drainage
Reduced medication burden: Long-term patients needed fewer NSAIDs and fewer gastroprotective drugs over time

Why Repeated HA Injections Are Different from Cortisone

Cortisone injections are limited to 3–4 per joint per year because repeated steroid exposure can accelerate cartilage breakdown. Gel injections carry no such risk. The EUROVISCO consensus guidelines specifically found no contraindications related to cumulative lifetime doses or total number of treatment courses.

This is a key distinction for long-term planning. If you need ongoing joint pain management for years, gel injections offer a sustainable option that cortisone cannot match. For a detailed side-by-side comparison, see our guide on cortisone vs. gel injections.


When to Consider Switching Brands or Treatments

Not every patient responds the same way to every brand. If your current gel injection is losing effectiveness, switching may help before abandoning the approach entirely.

Reasons to Try a Different Brand

Consider Switching Brands When:
  • Diminishing relief: Your current brand provides noticeably less pain reduction than it used to
  • Shorter duration: Relief that once lasted 8 months now fades at 4 months
  • Local reactions: Persistent swelling or pain flares beyond the normal first-week adjustment
  • Allergy concerns: Sensitivity to avian-derived products (switch to non-avian options like Euflexxa, Monovisc, Durolane, or Orthovisc)
  • Schedule preference: You want to switch from a multi-injection series to a single-injection option (or vice versa)

Most insurance policies require a trial of at least one complete course before concluding a brand is ineffective. Some insurers require failure with two preferred brands before approving non-preferred alternatives.

When to Consider Other Treatments Entirely

Gel injections are not always the right answer, even if they worked before. Talk with your doctor about alternatives if:

  • You have grade 4 (bone-on-bone) arthritis with full-thickness cartilage loss
  • Previous injections provided less than 10–15% pain improvement
  • Symptoms are severe enough to consider total knee replacement
  • You have explored and exhausted conservative options

Options to discuss include PRP injections, structured physical therapy, weight management, and surgical evaluation.


Private Insurance Retreatment Policies

Coverage for repeat gel injections varies significantly among private insurers. While Medicare has a clear, consistent policy, private plans range from generous to fully excluded.

Private Insurance Coverage Overview
Insurer TypeTypical PolicyNotes
MedicareCovered, 6-month intervalsNo lifetime limit
Medicare AdvantageUsually coveredMay require prior auth
UnitedHealthcareCoverage varies by planSome brands excluded
AetnaLimited coverageSpecific criteria required
Anthem/BCBSMany plans exclude entirelyCite AAOS guidelines
CignaPlan-dependentPrior auth common
HumanaGenerally coversSimilar to Medicare

Key Steps Before Each Repeat Course

  1. Verify your plan still covers HA injections — policies can change at annual renewal
  2. Check if prior authorization is required for each course (not just the first)
  3. Confirm the waiting period between courses (usually 6 months)
  4. Ask about lifetime or annual limits — some plans cap total courses
  5. Start the authorization process early — begin at month 5 if you typically need retreatment at month 6

For complete insurance navigation strategies, see our gel injection cost guide and insurance coverage guide.


Frequently Asked Questions

Is there a maximum number of times I can get gel injections?

No. There is no medical or Medicare-imposed lifetime limit on gel injection courses. Unlike cortisone (limited to 3–4 per year due to cartilage damage risk), hyaluronic acid can be repeated indefinitely as long as it continues to help. Many patients receive treatments every 6–12 months for a decade or longer.

Can I get gel injections every 6 months indefinitely?

Yes, provided they remain medically necessary and you continue responding to treatment. A 10-year prospective study confirmed that patients receiving injections every 6 months maintained significant pain reduction throughout the entire study period with no cumulative safety concerns.

Will gel injections stop working after several years?

The injections themselves do not lose potency. However, your underlying arthritis may progress over time, which can gradually reduce the degree or duration of relief. Most patients maintain meaningful benefit for many years. If you notice declining results, discuss brand switching or complementary treatments with your doctor.

Can I switch gel injection brands between courses?

Yes. If Synvisc-One was your first treatment, you could try Euflexxa, Monovisc, or any other FDA-approved brand for your next course. Different molecular weights and formulations may work better for different patients. Your doctor can help determine whether switching makes sense based on your response history.

What if my insurance denies a repeat treatment?

Work with your doctor’s office on an appeal. Key documentation includes proof that the previous course was effective (pain scores), evidence that symptoms have returned, and confirmation that conservative treatments remain inadequate. Most denials based on medical necessity can be overturned with proper documentation. Our prior authorization guide covers the appeals process in detail.

How do I know when it is time for my next injection?

Watch for returning symptoms: increasing morning stiffness, pain during activities that had improved, difficulty with stairs or walking, and pain levels approaching pre-injection severity. Some patients schedule proactively at the 6-month mark; others wait until symptoms return. Both approaches are reasonable.


Get Retreatment Reminders and Coverage Updates

Join thousands of patients staying informed about gel injection timing, Medicare changes, and insurance coverage updates.

You're in! Check your inbox.

Join 10,000+ readers. No spam.


Treatment Guides

Insurance and Coverage

Understanding Your Treatment


References

  1. Bowman EN, et al. “Hyaluronic acid injections for osteoarthritis of the knee: predictors of successful treatment.” Int Orthop. 2021;45(8):2021-2034. PMC8567800
  2. Henrotin Y, et al. “Efficacy and safety of repeated courses of intra-articular hyaluronic acid: a systematic review.” Semin Arthritis Rheum. 2018;47(5):739-748. PMID: 29496227
  3. CMS Medicare Coverage Database. LCD L39529: Viscosupplementation therapy for knee. cms.gov
  4. CMS Medicare Coverage Database. Article A56157: Viscosupplementation billing and coding. cms.gov
  5. Conrozier T, et al. “Variable volumes of hylan GF-20 over 6 months in knee osteoarthritis.” Clin Med Insights Arthritis Musculoskelet Disord. 2019;12. PMC6745818
  6. Lana JFSD, et al. “Prospective observational study of viscosupplementation with multiple courses: long-term efficacy.” J Clin Med. 2021;10(16):3574. PMC8364370
  7. SmartHealth. “Hyaluronan or derivative for intra-articular injection criteria for use.” mysmarthealth.org
  8. Tikiz C, et al. “Long-term viscosupplementation in hip osteoarthritis: 10-year prospective follow-up.” Clin Rheumatol. 2025. PMC12463173
  9. Strand V, et al. “Insurance coverage for intra-articular hyaluronic acid injections.” J Manag Care Spec Pharm. 2020;26(10):S18-S28. PMC7508284
  10. EUROVISCO Working Group. “Viscosupplementation consensus guidelines for knee and hip OA.” Ther Adv Musculoskelet Dis. 2024;16. PMC11577334
  11. Aetna. Clinical Policy Bulletin 0179: Viscosupplementation. aetna.com
  12. UnitedHealthcare. “Sodium hyaluronate medical drug policy.” uhcprovider.com
  13. Moda Health. “Hyaluronic acid derivatives prior authorization criteria.” modahealth.com

Last medically reviewed: March 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult with a qualified healthcare provider about treatment options for your specific condition.

Enjoyed this article?

Get more insights like this delivered to your inbox weekly.

You're in! Check your inbox.

Join 10,000+ readers. No spam.

Your Next Steps

What's Your Next Step?

You've learned about how often can you get gel injections? frequency and retreatment guide. Here's how to move forward:

Have questions? Contact us or call 1-800-555-0123